Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model

PLoS Computational Biology

Volumn 9, Issue 7, 2013, Pages

  Powathil, Gibin G ^a   Adamson, Douglas J A ^b   Chaplain, Mark A J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; CYTOLOGY; RADIATION DAMAGE; TUMORS;

CELL BEHAVIOURS; CELL CYCLE; CELL-BE; CELL/B.E; CELL/BE; CHEMOTHERAPY TREATMENT; COMPUTATIONAL MODELLING; INDIVIDUAL CELLS; RADIOTHERAPY TREATMENT; SOLID TUMORS;

RADIOTHERAPY;

CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOTOXIC AGENT; FLUOROURACIL; OXYGEN; TAXANE DERIVATIVE; VINCA ALKALOID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL FUNCTION; CELL HYPOXIA; CELL SYNCHRONIZATION; CELLULAR DISTRIBUTION; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; ESOPHAGUS CANCER; HUMAN; MATHEMATICAL MODEL; MULTIMODALITY CANCER THERAPY; PREDICTION; RADIATION DOSE; RADIOSENSITIVITY; SOLID TUMOR; TREATMENT RESPONSE; TUMOR CELL; TUMOR MICROENVIRONMENT;

EID: 84880794258     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003120     Document Type: Article

References (51)

1. Bailar JC, Gornik HL, (1997) Cancer undefeated. N Engl J Med 336: 1569-1574.
2. Schwartz GK, Shah MA, (2005) Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421.
3. Pawlik TM, Keyomarsi K, (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942.
4. Maity A, McKenna WG, Muschel RJ, (1994) The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 31: 1-13.
5. Fu K, (1985) Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 55: 2123-2130.
6. Hennequin C, Favaudon V, (2002) Biological basis for chemo-radiotherapy interactions. European Journal of Cancer 38: 223-230.
7. Panetta J, Adam J, (1995) A mathematical model of cycle-specific chemotherapy. Mathematical and Computer Modelling 22: 67-82.
8. Fister K, Panetta J, (2000) Optimal control applied to cell-cycle-specific cancer chemotherapy. SIAM Journal on Applied Mathematics pp. 1059-1072.
9. Liu W, Hillen T, Freedman H, (2007) A mathematical model for m-phase specific chemotherapy including the G0-phase and immunoresponse. Mathematical Biosciences and Engineering 4: 239.
10. Gardner SN, (2002) Cell cycle phase-specific chemotherapy: computational methods for guiding treatment. Cell Cycle 1: 369-374.
11. Ribba B, Colin T, Schnell S, (2006) A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theor Biol Med Model 3: 7.
12. Richard M, Kirkby K, Webb R, Kirkby N, (2007) A mathematical model of response of cells to radiation. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 255: 18-22.
13. Bekkal Brikci F, Clairambault J, Ribba B, Perthame B, (2008) An age-and-cyclin-structured cell population model for healthy and tumoral tissues. J Math Biol 57: 91-110.
14. Hillen T, De Vries G, Gong J, Finlay C, (2010) From cell population models to tumor control probability: Including cell cycle effects. Acta Oncologica 49: 1315-1323.
15. Powathil GG, Gordon KE, Hill LA, Chaplain MA, (2012) Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid multiscale cellular automaton model. J Theor Biol 308: 1-9.
16. Enderling H, Anderson AR, Chaplain MA, Munro AJ, Vaidya JS, (2006) Mathematical modelling of radiotherapy strategies for early breast cancer. J Theor Biol 241: 158-171.
17. Powathil G, Kohandel M, Sivaloganathan S, Oza A, Milosevic M, (2007) Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy. Physics in Medicine and Biology 52: 3291.
18. Harting C, Peschke P, Borkenstein K, Karger C, (2007) Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation. Physics in Medicine and Biology 52: 4775.
19. Rockne R, Alvord E, Szeto M, Gu S, Chakraborty G, et al. (2008) Modeling diffusely invading brain tumors an individualized approach to quantifying glioma evolution and response to therapy. Selected Topics in Cancer Modeling pp. 1-15.
20. Enderling H, Park D, Hlatky L, Hahnfeldt P, (2009) The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor Radioresponse. Mathematical Modelling of Natural Phenomena 4: 117-133.
21. Enderling H, Chaplain M, Hahnfeldt P, (2010) Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheoretica 58: 341-353.
22. Tannock I, Hill R, Bristow R, Harrington L (2005) Basic Science of Oncology. Boston: MacGraw Hill, 2005.
23. Chaudhry MA, (2007) Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases. Cancer Cell Int 7: 15.
24. Goto S, Watanabe M, Yatagai F, (2002) Delayed cell cycle progression in human lymphoblastoid cells after exposure to high-LET radiation correlates with extremely localized DNA damage. Radiat Res 158: 678-686.
25. Gyllenberg M, Webb GF, (1990) A nonlinear structured population model of tumor growth with quiescence. J Math Biol 28: 671-694.
26. Kendal WS, (1985) Gompertzian growth as a consequence of tumor heterogeneity. Mathematical Biosciences 73: 103-107.
27. Kozusko F, Bajzer Z, (2003) Combining Gompertzian growth and cell population dynamics. Math Biosci 185: 153-167.
28. Suzuki Y, Nakano T, Ohno T, Kato S, Niibe Y, et al. (2006) Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer. Int J Gynecol Cancer 16: 306-311.
29. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, et al. (1995) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55: 3564-3568.
30. Andrade LM, Geraldo JM, Goncalves OX, et al. (2012) Nucleoplasmic Calcium Buffering Sensitizes Human Squamous Cell Carcinoma to Anticancer Therapy. J Cancer Sci Ther 4: 131-139.
31. Goda N, Dozier SJ, Johnson RS, (2003) HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 5: 467-473.
32. Powathil G, Kohandel M, Milosevic M, Sivaloganathan S, (2012) Modeling the spatial distribution of chronic tumor hypoxia: implications for experimental and clinical studies. Comput Math Methods Med 2012: 410602.
33. Hennequin C, Giocanti N, Favaudon V, (1996) Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res 56: 1842-1850.
34. Gupta S, Koru-Sengul T, Arnold SM, Devi GR, Mohiuddin M, et al. (2011) Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol Cancer Ther 10: 292-302.
35. Jemal A, Bray F, Center M, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
36. Herskovic A, Martz K, al Sarraf M, Leichman L, Brindle J, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598.
37. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623-1627.
38. Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M, (2012) Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol 23: 1095-1103.
39. Hurt CN, Nixon LS, Griffiths GO, Al-Mokhtar R, Gollins S, et al. (2011) SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer 11: 466.
40. Tyson JJ, Novak B, (2001) Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol 210: 249-263.
41. Novak B, Tyson JJ, (2003) Modelling the controls of the eukaryotic cell cycle. Biochem Soc Trans 31: 1526-1529.
42. Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA, (2001) A cellular automaton model of early tumor growth and invasion. J Theor Biol 213: 315-331.
43. Dasu A, Toma-Dasu I, Karlsson M, (2003) Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys Med Biol 48: 2829-2842.
44. Jain RK, Tong RT, Munn LL, (2007) Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathe-matical model. Cancer Res 67: 2729-2735.
45. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, et al. (1999) Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80: 724-732.
46. Sachs RK, Hahnfeld P, Brenner DJ, (1997) The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 72: 351-374.
47. Alper T, Howard-Flanders P, (1956) Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 178: 978-979.
48. Wouters BG, Brown JM, (1997) Cells at intermediate oxygen levels can be more important than the hypoxic fraction in determining tumor response to fractionated radiotherapy. Radiat Res 147: 541-550.
49. Titz B, Jeraj R, (2008) An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response. Phys Med Biol 53: 4471-4488.
50. Guerrero M, Li XA, (2003) Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning. Phys Med Biol 48: 3307-3326.
51. Turesson I, Carlsson J, Brahme A, Glimelius B, Zackrisson B, et al. (2003) Biological response to radiation therapy. Acta Oncol 42: 92-106.